CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 39 pages
The Cost -effectiveness of a Potential Pentavalent Meningococcal Conjugate Vaccine (Men ABCWY) versus the Current Men ACWY and Men B vaccines for US Adolescents Ismael R. Ortega -Sanchez, PhD CDC/NCIRD ACIP meeting, June 23, 2023 Disclaimer : The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. 1 2Conflict of Interest CDC/NCIRD collaborators: All collaborators, No conflict of…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 85 pages
National Center for Immunization & Respiratory Diseases Evidence to Recommendations Framework: Pfizer’s MenABCWY Vaccine Sam Crowe, PhD, MPH Meningococcal Vaccines Work Group Lead June 23, 2023 Outline ▪Overview of policy questions and PICOs ▪Evidence to Recommendations framework ▪Summary of findings ▪WG proposed options 2 Pfizer MenABCWY Vaccine ▪Comprised of Trumenba (serogroup B) and Nimenrix (serogroups ACWY) –Trumenba •Consists of two purified recombinant lipidated FHbp antigens, one…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 7 pages
National Center for Emerging and Zoonotic Infectious Diseases Vaccine safety updates Advisory Committee on Immunization Practices (ACIP) meeting June 23, 2023 Tom T. Shimabukuro, MD, MPH, MBA Director, Immunization Safety Office Division of Healthcare Quality Promotion Centers for Disease Control and Prevention (CDC) Session topics ▪Background on the CDC Immunization Safety Office (ISO) and ISO efforts to evaluate studying the safety of the childhood immunization schedule (Dr. Tom…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 20 pages
The Childhood Immunization Schedule and Safety: Studies in the Vaccine Safety Datalink Matthew F. Daley MD Advisory Committee on Immunization Practices, June 23, 2023 KAISER PERMANENTE INSTITUTE FOR HEALTH RESEARCH •No conflicts of interest to disclose •The findings in this presentation are those of the speaker and do not necessarily represent the official position of the Centers for Disease Control and PreventionDisclaimers Schedule and Safety 2 KAISER PERMANENTE INSTITUTE FOR HEALTH…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 12 pages
Preliminary evaluation of aluminum content in childhood vaccines and risk of asthma in a Danish nationwide cohort Prof. Anders Hviid, Statens Serum Institut, Copenhagen, Denmark Advisory Committee on Immunization Practices, June 23, 2023 Study cohort •Born in Denmark 2009 -2016 •Study start 1/1 2011 ; study end 12/31 2018 •Follow -up from 2 to 5 -years -of-age •Exposure and outcome data from nationwide - registers •N=470,477 children 2 The Danish schedule 3Danish schedule 3 mo.: …
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 8 pages
cdc.gov/coronavirus ACIP COVID -19 Vaccines Work Group Dr. Matthew F. Daley, Work Group Chair June 23, 2023 ▪COVID -19 vaccine program updates ▪Vaccine safety updates ▪Vaccine effectiveness data updates ▪Data and Work Group considerations for updates to vaccine policy –Single bivalent vaccine dose for most persons aged ≥6 years –Bivalent vaccines for children aged 6 months –5 years –Optional additional bivalent doses for persons aged ≥6 months who are moderately or severely…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 62 pages
cdc.gov/coronavirus Epidemiology of COVID -19-Associated Hospitalizations, including in Pregnant Persons and Infants Fiona Havers, MD, MHS, FIDSA Team Lead, RESP -NET Hospitalization Surveillance Team Commander, US Public Health Service Coronavirus and Other Respiratory Viruses Division National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention Advisory Committee on Immunization Practices June 23, 2023 COVID -19-associated hospitalizations COVID -NET:…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 14 pages
cdc.gov/coronavirusInfection -induced and hybrid immunity Jefferson Jones, MD MPH FAAP CDR, US Public Health Service Shifts in vaccine -induced, infection -induced, and hybrid immunity against SARS -CoV-2 among blood donors aged ≥16 years —United States, Quarter 2 2021 –Quarter 3 2022 No infection or vaccination Vaccine only -induced antibodies Infection only -induced antibodies Both infection and vaccination -induced antibodies (hybrid immunity) Jones MMWR 2023: Data from a…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 25 pages
Economics of Potential Pentavalent Meningococcal Conjugate Vaccine (MenABCWY) versus the Current MenACWY and MenB vaccines for US Adolescents A SUMMARY REPORT COMPARING MODELS FROM: Pfizer AND CDC Ismael R. Ortega-Sanchez, PhD NCIRD/CDC Meningococcal ACIP Meeting, October 25, 2023 Disclaimer : The findings and conclusions in this report are t hose of the authors and do not necessarily represen t the views of the Centers for Disease Control and Prevention. National Center for…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 42 pages
Summary of EtRand proposed recommendations for Pfizer’s MenABCWY vaccine Jennifer Collins MD, MSc Interim Co -Lead, ACIP Meningococcal Vaccines Work Group October 25, 2023National Center for Immunization & Respiratory Diseases ACIP Recommendations for Meningococcal Vaccines ▪ Routine schedule –MenACWY : dose 1 at age 11 –12 years, booster dose at age 16 years –MenB (shared clinical decision -making): two doses at age 16–23 years (preferred age 16 –18 years) ▪ Special situations…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 17 pages
National Center for Emerging and Zoonotic Infectiou s Diseases Mpox Vaccine Work Group: Introduction ACIP Meeting October 25, 2023 Pablo Sanchez MD /uni00YJhe Ohio State /uni00YYni/uni00-6ersit/uni00-9/uni2212Na/gJ1Yon/uni00--ide Children/uni2019s /uni00J8osp ital Chair, ACIP Mpox Work Group Global mpox outbreak, 2022 First case in this outbreak identified in the Unite d Kingdom in May 2022 Primarily affecting gay, bisexual, and other men wh o have sex with men (MSM) Associated…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 40 pages
National Center for Emerging and Zoonotic Infectiou s Diseases 2022/2023 Mpox Outbreak: Situational Awareness and Updates ACIP Meeting October 25, 2023 Faisal Syed Minhaj, PharmD, MPH, DABAT Epidemiologist Poxvirus and Rabies Branch Division of High Consequence Pathogens and Patholog y United States Mpox Case Counts May 2022–Sept 28, 202 3 https://www.cdc.gov/poxvirus/mpox/response/2022/mpx -trends.html /uni004D/uni0061/uni0079/uni002D/uni0032/uni0033…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 45 pages
National Center for Emerging and Zoonotic Infectiou s Diseases Evidence to Recommendations Framework: Vaccination with JYNNEOS for Persons At Risk of Mpo x Advisory Committee on Immunization Practices October 25, 2023 Agam Rao, MD CAPT, US Public Health Service Poxvirus and Rabies Branch Centers for Disease Control and Prevention Evidence to Recommendations (EtR) Framework Structure to describe information considered in moving fr om evidence to ACIP vaccine recommendations Provides…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 15 pages
National Center for Emerging and Zoonotic Infectiou s Diseases Clinical guidance and next steps Advisory Committee on Immunization Practices October 25, 2023 Agam Rao, MD CAPT, US Public Health Service Poxvirus and Rabies Branch Centers for Disease Control and Prevention Guidance about vaccination before exposures to mpox Similar to what has previously been presented to ACIP Specific to pre-exposure vaccination Specific to the population at risk for mpox* *Interim recommendation to be…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 8 pages
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Di seases Photographs and images included in this presentation a re licensed solely for CDC/NCIRD online and present ation use. No rights are implied or extended for use in pr inting or any use by other CDC CIOs or any external audiences. Adult Respiratory Syncytial Virus (RSV) Session Camille Kotton, MD Chair, Adult RSV Work Group Advisory Committee on Immunization Practices (ACIP)October 25,…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 26 pages
CO-1 ACIP October 25, 2023 Susan Gerber, MD Medical Director Presentation by GSK at ACIP Oct 25, 2023 CO-2 Substantial RSV Disease Burden and Unmet Medical Need in US Adults Aged 50 –59 Years RSV-associated hospitalizations and medically -attended RSV illnesses are substantial among 50 -59 YOA Published incidence rates likely substantially underestimate RSV burden due to lack of awareness, standardized testing, and underdetection within surveillance studies Comorbidities associated with…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 39 pages
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Di seases Photographs and images included in this presentation a re licensed solely for CDC/NCIRD online and present ation use. No rights are implied or extended for use in pr inting or any use by other CDC CIOs or any external audiences. Epidemiology of Respiratory Syncytial Virus Hospitalizations in Adults — RSV-NET Advisory Committee on Immunization Practices, October 2 5, 2023 Monica E. Patton,…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 26 pages
Centers for Disease Control and Prevention National Center for Immunization and Respiratory Di seases Photographs and images included in this presentation a re licensed solely for CDC/NCIRD online and present ation use. No rights are implied or extended for use in pr inting or any use by other CDC CIOs or any external audiences. ACIP Adult RSV Work Group Considerations Respiratory Syncytial Virus (RSV) in Adults Use of RSV vaccines in adults aged 50–59 years Amadea Britton, MD, MS…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 7 pages
National Center for Immunization & Respiratory Diseases Influenza Work Group —Introduction Dr. Jamie Loehr (Work Group Chair) Advisory Committee on Immunization Practices October 25, 2023 Influenza Work Group ACIP Members •Jamie Loehr (Chair) •Keipp Talbot •Camille Kotton Ex Officio •Timothy Brennan (FDA) •Uzo Chukwuma (IHS) •Jeffrey Kelman (CMS) •Valerie Marshall (OASH) •Cynthia Nolletti (FDA) •Chris Roberts (NIH)Liaison Representatives and Consultants •Robert Atmar •Kevin Ault •Ed Belongia…
CDC ACIP — Vaccine Advisory Committee
· Acip
/ Slides
· 19 pages
Safety of quadrivalent recombinant influenza vaccine in pregnant women and their infants Nicky Klein, MD, PhD Director, Kaiser Permanente Vaccine Study Center Kaiser Permanente Northern California Advisory Committee on Immunization Practices Meeting October 25, 2023 Disclosures •Sanofi provide related research support for 'Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18- 64 Years' (NCT03694392). •Sanofi provided all the recombinant…